CJC + IPA 5mg+5mg
Combination vial: CJC-1295 (5mg) + Ipamorelin (5mg). Studied for synergistic stimulation of the growth hormone axis. GH pulsatility and somatotropic research.
Product specifications
| Product | CJC + IPA |
| Quantity | 5mg + 5mg |
| Format | Lyophilised Powder |
| Listed purity | ≥98% |
| Storage | Store at -20°C. Reconstituted: 2–8°C, use within 21 days. |
Research information
CJC-1295 is a DAC-modified GHRH analogue with extended half-life. Ipamorelin is a selective GH secretagogue. Together studied for GH axis regulation.
Research use only.
This product is supplied strictly for legitimate scientific research and is not intended for human or veterinary consumption. Product information is not medical advice and should not be interpreted as a recommendation for use in people or animals.
This product is supplied strictly for legitimate scientific research and is not intended for human or veterinary consumption. Product information is not medical advice and should not be interpreted as a recommendation for use in people or animals.